| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Published online before print September 6, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
on Cytokine-Activated T Cells
,
,
,
From the Department of Internal Medicine, Division of Rheumatology,* Rheumatic Disease Core Center, the Department of Surgery,
Section of Plastic Surgery, and the Department of Orthopedic Surgery,
University of Michigan Medical School, Ann Arbor, Michigan; and the School of Molecular Biosciences,
Washington State University, Pullman, Washington
@ To whom correspondence should be addressed. E-mail: dfox{at}umich.edu.
| Abstract |
|---|
The mechanism of fibroblast-like synoviocyte (FLS) transformation into an inflammatory phenotype in rheumatoid arthritis (RA) is not fully understood. FLS interactions with invading leukocytes, particularly T cells, are thought to be a critical component of this pathological process. Resting T cells and T cells activated through the T-cell receptor have previously been shown to induce inflammatory cytokine production by FLS. More recently, a distinct population of T cells has been identified in RA synovium that phenotypically resembles cytokine-activated T (Tck) cells. Using time lapse microscopy, the interactions of resting, superantigen-activated, and cytokine-activated T cells with FLS were visualized. Rapid and robust adhesion of Tck and superantigen-activated T cells to FLS was observed that resulted in flattening of the T cells and a crawling movement on the FLS surface. Tck also readily activated FLS to produce interleukin IL-6 and IL-8 in a cell contact-dependent manner that was enhanced by exogenous IL-17. Although LFA-1 and ICAM-1 co-localized at the Tck-FLS synapse, blocking the LFA-1/ICAM-1 interaction did not substantially inhibit Tck effector function. However, antibody blocking of membrane tumor necrosis factor (TNF)-
on the Tck surface did inhibit FLS cytokine production, thus illustrating a novel mechanism for involvement of TNF-
in cell-cell interactions in RA synovium and for the effectiveness of TNF-
blockade in the treatment of RA.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |